Home > Back to Publisher > Report Information

North American Animal Health Regulations (2 volumes)

Informa Healthcare
June 1, 2007
83 Pages - SKU: IFHC1695584

Abstract Table of Contents Related Reports

Countries covered: North America

In the United States, there are three agencies that regulate animal health. It is important to understand this and to realize that for a non drug product, a different agency in the US may have jurisdiction and, consequently, approval power.This report, which has two volumes, is aimed at anyone who needs to understand the basics of animal health regulations in North America. Volume I looks at the legislative framework in place whilst Volume II concentrates on the practical side of submitting an application for market authorization.

Key coverage

Take a detailed look at the legislative and regulatory framework in place.
Understand how to bring an animal drug product to market in the US effectively and efficiently.
Use Volume 2 of the report as a practical guide taking you through the application processes - with invaluable do’s and don’ts to help make a more favorable impression.
Find out the procedures for renewals, variations & extensions, generics and good practice guidelines and more - providing you with a one stop resource.

Key issues

Learn the roles of the three agencies regulating animal health in the US including, the US Department of Agriculture which regulates animal biological product, the US Environment Protection Agency which regulates pesticide products used on animals and the Food and Drug Administration (FDA) regulates products considered to be animal drugs.
Find out the main acts and the FDA regulations as well as guidance on getting approvals and practical tips to speed up the approval process.
Volume I of the report looks closely at getting approval for generics products in the US.
Volume II guides you carefully through the intricacies of the pre-approval process, as well as the main application and any post-approval requirements.
Also included is them process at the Venter for Veterinary Medicine (CVM) for supplemental applications to change or modify the original approved application.

Chapters include:
US Laws, US Pharmacopoeia, FD regulations, FDA guidance documents and guidelines, access to US materials, generic products, regulatory process for generic animal drugs, approval requirements for the ANADA, product variations permitted under the GADPTRA, filing new applications.Who should read this report?
This report will be an ideal guide for:

Newcomers to the regulatory profession
Generics manufacturers in or outside of North America
Or drug developers wanting to market their products in North America.

Please Note: This product is delivered as a zip file, which contains PDF files.

VOLUME 1
CHAPTER 1 US LAWS: 1.1 The laws; 1.2 US Pharmacopoeia
CHAPTER 2 FDA REGULATIONS: 2.1 Title 21 Code of Federal Regulations Part 25 (21 CFR 25); 2.2 Title 21 Code of Federal Regulations Part 58 (21 CFR 58); 2.3 Title 21 Code of Federal Regulations Part 210 (21 CFR 210); 2.4 Title 21 Code of Federal Regulations Part 500 (21 CFR 500)
CHAPTER 3 FDA GUIDANCE DOCUMENTS AND GUIDELINES
CHAPTER 4 ACCESS TO US MATERIALS: 4.1 FOI Summaries; 4.2 The laws; 4.3 The regulations; 4.4 Guidance documents; 4.5 Concluding remarks
CHAPTER 5 GENERIC PRODUCTS: 5.1 Background to the legislation; 5.2 Abbreviated New Drug Applications; 5.3 Patent term restoration; 5.4 Provisions for animal drugs
CHAPTER 6 REGULATORY PROCESS FOR GENERIC ANIMAL DRUGS
CHAPTER 7 APPROVAL REQUIREMENTS FOR THE ANADA
CHAPTER 8 PRODUCT VARIATIONS PERMITTED UNDER THE GADPTRA: 8.1 Suitability Petition; 8.2 Hybrid Application
VOLUME 2
CHAPTER 1 THE COMPOUND IS IDENTIFIED: 1.1 What will the molecule do?; 1.2 Can the molecule be used safely?; 1.3 Developing the draft label; 1.4 Outlining the program of development
CHAPTER 2 BACKGROUND PACKAGE AND NEW ANIMAL DRUG APPLICATION
CHAPTER 3 THE PRE-SUBMISSION CONFERENCE: 3.1 Getting the meeting date; 3.2 Preparing for the Pre-submission Conference; 3.3 The Pre-submission Conference
CHAPTER 4 PROTOCOL SUBMISSIONS
CHAPTER 5 SUBMISSION OF DATA: 5.1 Technical Sections
CHAPTER 6 FILING NEW APPLICATIONS
CHAPTER 7 PHASED REVIEWS
CHAPTER 8 TECHNICAL SECTIONS: 8.1 Chemistry, Manufacturing, and Controls; 8.2 Components and Composition; 8.3 Samples; 8.4 Effectiveness; 8.5 Target Animal Safety; 8.6 Human Food Safety; 8.7 Labeling; 8.8 FOI Summary; 8.9 All Other Information; 8.10 Technical Section submission
CHAPTER 9 REVIEW OF THE DATA
CHAPTER 10 APPROVAL OF TECHNICAL SECTIONS AND THE NEW ANIMAL DRUG APPLICATION
CHAPTER 11 POST APPROVAL REQUIREMENTS: 11.1 Advertising and promotional materials; 11.2 Drug experience reporting
CHAPTER 12 SUPPLEMENTAL APPLICATIONS: 12.1 Category I supplements; 12.2 Category II supplements

More North America Prescription Drugs Reports

2012 Healthcare Business Market Research Handbook by Richard K. Miller & Associates
The 2012 Healthcare Business Market Research Handbook presents a comprehensive analysis of the $2.8 trillion U.S. healthcare marketplace with the most recent statistics and data ...

Canada Pharmaceutical Industry by Aruvian's R'search
The Canadian pharmaceutical market is the eighth largest in the world, accounting for about two percent of the world market by sales. Canada also has ...

Brand Name Pharmaceutical Manufacturing in the US - Industry Market Research Report by IBISWorld
Brand Name Pharmaceutical Manufacturing in the US Prescription for growth With healthcare reform allowing more individuals to gain prescription coverage, brand-name pharmaceutical and medicine manufacturers will experience ...

Analysis of the United States Contract Manufacturing Outsourcing Market by Frost & Sullivan
Contract manufacturing outsourcing (CMO) companies provide independent manufacturing services for pharmaceutical and biotechnological markets. This study covers the U.S. commercial manufacturing and packaging of pharmaceutical ...

United States Pharmaceuticals and Healthcare Report Q2 2012 by Business Monitor International
BMI View: Economics and politics are increasingly exerting an influence on the US pharmaceuticalmarket. This is in stark contrast to the late 1990s and early ...

See all reports like this >>

More North America Reports

Spirits – Mexico – a snapshot (2011) by Mintel - Snapshots
Spirits in Mexico by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers all ...

e-Discovery Software Publishing in the US - Industry Market Research Report by IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...

D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country RiskLine Report: Mexico by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country RiskLine Report: Canada by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

See all reports like this >>

North American Animal Health Regulations (2 volumes)

Share this report

Other tasks

Research Assistance

Related Markets

Prescription Drugs Reports

Free Alert Me service